Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study shows depressed heart disease patients fail to take prescribed life-saving medication

10.03.2005


Columbia University Medical Center study shows link between depression and worsening heart disease

Depression is known to be "hard on the heart" – now researchers are a step closer to understanding why. A new Columbia University Medical Center study examining potential links between depression and heart disease found that heart disease patients who showed symptoms of depression were substantially less adherent to taking a prescribed medicine than patients without depression. Patients who continued to show signs of depression three months after a heart attack or angina only took prescribed medications 67 percent of the time, compared to almost 90 percent in non-depressed patients.

The research, which was presented for the first time at the 63rd American Psychosomatic Society Annual Meeting is part of the Coronary Psychosocial Patient Evaluation Study (COPES), a multi-site, multi-project consortium that is funded by the National Heart, Lung, and Blood Institute. According to Karina W. Davidson, Ph.D., assistant professor of medicine at Columbia University Medical Center and principal investigator of the study, it was known that depression in heart disease patients increases the risk of death after a heart attack, but the explanation for the link had remained unclear until now.



"Taking your medication as prescribed is crucial for improving your chances of good recovery after a heart attack but many doctors struggle with getting patients to take their medication on schedule," said Dr. Davidson. "Our study was designed to test if depression may be a significant factor in reducing adherence, thus potentially explaining why depression carries such a negative prognosis for the heart disease patients."

The study showed that patients who were not depressed in hospital were highly adherent – they took the correct dosage of aspirin on 88% of all monitored days. The researchers then divided the depressed patients into 2 subgroups: those who remained depressed 3 months after the ACS, and those whose depressive symptoms had remitted by then. Only patients with persistent levels of depression significantly differed in their level of adherence from non-depressed patients: they took the correct dosage only 2/3 or 67% of the time, as compared to 86% in patients whose depressive symptoms spontaneously remitted after 3 months.

"This is a huge difference that could have an impact on patient survival", concludes Dr. Davidson. "Moreover, it is of great significance to cardiologists and their patients, since medication adherence is a relatively simple, potentially modifiable behavior."

The study objectively measured adherence to aspirin, a standard medication in heart disease patients, by using an electronic Medication Event Monitoring System (MEMS) - an electronic device stored in the cap of a pill bottle that records the date and time whenever the cap is opened. The study included 53 patients from the coronary care and cardiac care step-down units of three university hospitals who had survived an Acute Coronary Syndrome (ACS), which includes either a heart attack or documented unstable angina.

Dr. Davidson’s research will continue to examine the link between depression and heart disease by examining whether effectively treating depression in these patients will result in better medication adherence and subsequently a decrease in mortality.

Craig LeMoult | EurekAlert!
Further information:
http://www.columbia.edu

More articles from Studies and Analyses:

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

nachricht Scientists reveal source of human heartbeat in 3-D
07.08.2017 | University of Manchester

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>